Cocaine-binding antibodies have shown some promise in their ability to neutralize cocaine toxicity, but their binding ability is severely impaired by high concentrations of the drug. A catalytic monoclonal antibody such as 7A1, on the other hand, has the ability to regenerate after each new dose of the drug, making it far more effective than others in metabolizing cocaine.

The Center will use IBM technologies to advance research into new drugs for the treatment of some of today's most life-threatening diseases, including cancer. The Center's research will be headed by one of the world's leading systems biologists, Dr. Jeffrey Skolnick, the Georgia Research Alliance Eminent Scholar in Computational Systems Biology.

Removing a gene involved in repairing damaged DNA causes mice to develop the metabolic syndrome, researchers at Oregon Health & Science University have discovered.

The Department of Health and Human Services (HHS) today announced the creation of two new, closely related initiatives to speed up research on the causes of common diseases such as asthma, arthritis and Alzheimer's disease.